Revolutionize AMD Treatment with PBM Therapy
Integrate the eye-light® device into your practice for non-invasive, scientifically validated Photobiomodulation (PBM) therapy.
Targeting AREDS 3 and lower, it slows dry AMD progression using Light Modulation LLLT.
Red (630nm) boosts ATP, restores mitochondria, and reduces inflammation, while Yellow (590nm) inhibits VEGP to limit abnormal blood vessel growth.
Enhance patient care and practice profitability today!
